What
does congestive heart failure, gum disease and obesity have in common?
Very often, a deficiency of coenzyme Q10 (CoQ10). A lack of CoQ10 has
also been implicated in arrhythmias, strokes, hypertension, heart
attacks, atherosclerosis, muscular dystrophy and AIDS and many of these
diseases can be prevented and treated successfully with CoQ10. Since its
discovery and isolation 40 years ago hundreds of clinical research
studies have been done on CoQ10 and it is now abundantly clear that this
nutrient is absolutely vital to health(1-5).
Coenzyme Q10 (ubiquinone/ubiquinol) is
a fat-soluble quinone with a structure similar to that of vitamin K. It
is a powerful antioxidant both on its own and in combination with
vitamin E and is vital in powering the body's energy production (ATP)
cycle. CoQ10 is found throughout the body in cell membranes, especially
in the mitochondrial membranes and is particularly abundant in the
heart, lungs, liver, kidneys, spleen, pancreas and adrenal glands. The
total body content of CoQ10 is only about 500-1500 mg and decreases with
age(5).
Coenzyme Q10 has received particular attention
in the prevention and treatment of various forms of cardiovascular
disease. It is highly effective in preventing the oxidation of
low-density lipoprotein cholesterol (LDL) which leads to
atherosclerosis(2,6-8). Several studies have shown that patients with
congestive heart failure and other cardiovascular diseases have
significantly lower levels of CoQ10 in their heart tissue than do
healthy people and supplementation with as little as 100 mg/day has been
shown to markedly improve their condition. CoQ10 is now approved in
Japan for the treatment of congestive heart failure(2-5,9,10).
Heart attacks and strokes produce a
burst of free radicals (ischemia- reperfusion) which can result in
extensive tissue damage. Patients with high CoQ10 levels suffer less
damage from these events and Japanese researchers have found that CoQ10
supplementation prior to and immediately following open heart surgery is
highly beneficial in preventing reperfusion injury - a common
complication in heart surgery(2,4,5,11,12). Supplementation with CoQ10
has also been found beneficial in patients with chronic stable angina,
mitral valve prolapse and irregular heart beat (arrhythmias)(2-5,13-15).
Coenzyme Q10 has also proven useful in
the treatment of various cardiomyopathies (diseases of the heart muscle
that reduces its pumping capacity). Studies have shown that
supplementation with as little as 100 mg/day for 12 months results in
better pumping capacity (increased ejection fraction), increased muscle
strength and improved breathing(2- 4,16).
Several studies indicate that CoQ10 may
be beneficial in the treatment of hypertension (high blood pressure). A
study of 109 patients with long-standing, essential hypertension, who
were on antihypertensive drugs, concluded that supplementation with an
average of 225 mg/day of CoQ10 improved functional status, allowed about
half the patients to discontinue most of their blood pressure
medications and resulted in an average decrease of systolic blood
pressure from 159 to 147 mm Hg and a diastolic pressure decrease from 94
to 85 mm Hg. Smaller, more recent Japanese studies have confirmed these
findings(2-5,17-19).
Studies at the University of Ancona in
Italy have provided evidence that CoQ10 supplementation reduces blood
levels of epinephrine (adrenalin) and other catecholamines; this is
believed to be partly responsible for the drop in blood pressure and may
also explain why CoQ10 is effective in reducing the incidence of certain
types of arrhythmias(2,20).
Coenzyme Q10 is a great boost
to heart health, but it has many other beneficial effects. Strenuous
physical exercise reduces blood levels of CoQ10 and supplementation with
60 mg/day has been found to improve athletic performance(2,3,21).
Administration of CoQ10 alone or in combination with vitamin B6
(pyridoxine) boosts the immune system and may be useful in the treatment
of AIDS and other infectious diseases(3,22,23). An adequate level of
CoQ10 in the body is essential to proper muscle functioning and several
studies have indeed shown that supplementation with 100-150 mg/day of
CoQ10 markedly improves the condition of people suffering from muscular
dystrophy(2-5,25-28).
Many overweight people have very low
levels of CoQ10 and supplementation may enable them to lose weight due
to the effect of CoQ10 in speeding up the metabolism of fats(3,4,29).
Some very recent, highly intriguing
research carried out at the Institute of Neurosciences in Argentina has
shown that brain activity and alertness is enhanced in hypertensive
patients within one hour of oral administration of 100 mg of CoQ10(30).
CoQ10 has been used with
success in combating periodontal diseases, especially gingivitis (gum
disease). Tissue affected by gingivitis is deficient in CoQ10 and
experiments have shown that supplementation with as little as 50 mg/day
can decrease inflammation. More recent research has shown that topical
application of CoQ10 dissolved in soya oil (85 mg/ml) to affected areas
(periodontal pockets) reduces bleeding and the depth of the
pockets(2-5,31-34).
Research carried out in Denmark has
provided some tantalizing evidence that CoQ10 may also be effective in
the fight against certain cancers. A trial involving the treatment of 32
breast cancer patients with megadoses of vitamins, minerals, essential
fatty acids and coenzyme Q10 (90 mg/day) in addition to conventional
therapy showed a highly beneficial effect of the supplementation. Two of
the patients in the trial whose tumors had not regressed had their CoQ10
dosages increased to 390 mg/day and 300 mg/day respectively with the
result that their tumors disappeared completely within three
months(3,35). CoQ10 supplementation is also very important for cancer
patients undergoing chemotherapy with heart toxic drugs such as
adriamycin and athralines. Recent research has also shown that certain
cholesterol-lowering drugs (lovastatin, etc.) block the natural
synthesis of CoQ10 so supplementation with 100 mg/day is recommended for
patients taking these drugs(2,3,36).
The body can synthesize
coenzyme Q10 and it is also found in several dietary sources, notably
organ meats. The level of CoQ10 in human organs peaks around the age of
20 years and then declines fairly rapidly. The decrease in CoQ10
concentration in the heart is particularly significant with a
77-year-old person having 57 per cent less CoQ10 in the heart muscle
than a 20-year-old(30). Some experts involved in CoQ10 research believe
that many people, especially older people and people engaging in
vigorous exercise may be deficient in CoQ10 and may benefit from
supplementation. The recommended daily dosage for health maintenance is
30 mg; however, considerably higher amounts are required in the
treatment of the various diseases for which supplementation has been
found beneficial(2,3,37,38). CoQ10 should be taken with a meal
containing some fat or even better, in combination with soya or
vegetable oil which enhances its absorption quite substantially(3).
CoQ10 supplements are readily absorbed by the body and no toxic effects
have been reported for daily dosages as high as 300 mg. The safety of
CoQ10, however, has not been established in pregnancy and lactation, so
caution is advised here until more data becomes available(3,5). CoQ10
30mg
A Healthy Alternative,
LLC, manufactures very high quality vitamins and mineral products and is very
well known for it's wonder herb Imperial Gold Maca™ You can examine
what is available here.
Coenzyme Q-10 REFERENCES:
- Kagan, Valerian E., et al. Coenzyme Q: Its role in
scavenging and generation of radicals in membranes. In Handbook of
Antioxidants, eds. Enrique Cadenas and Lester Packer, NY, Marcel
Dekker, Inc., 1996, pp. 157-201
- Littarru, Gian Paolo, et al. Clinical aspects of
coenzyme Q: Improvement of cellular bioenergetics or antioxidant
protection? In Handbook of Antioxidants, eds. Enrique Cadenas and
Lester Packer, NY, Marcel Dekker, Inc., 1996, pp. 203-39
- Murray, Michael T. Encyclopedia of Nutritional
Supplements, Rocklin, CA, Prima Publishing, 1996, pp. 296-308
- Bliznakov, Emile G. and Hunt, Gerald L. The Miracle
Nutrient Coenzyme Q10. NY, Bantam Books, 1986
- Greenberg, Steven and Frishman, William H.
Co-enzyme Q10: A new drug for cardiovascular disease. Journal of
Clinical Pharmacology, Vol. 30, 1990, pp. 596-608
- Frei, Balz, et al. Ubiquinol-10 is an effective
lipid-soluble antioxidant at physiological concentrations.
Proceedings of the National Academy of Sciences USA, Vol. 87, June
1990, pp. 4879-83
- Stocker, Roland, et al. Ubiquinol-10 protects human
low density lipoprotein more efficiently against lipid peroxidation
than does alpha-tocopherol. Proceedings of the National Academy of
Sciences USA, Vol. 88, March 1991, pp. 1646-50
- Hanaki, Yoshihiro, et al. Ratio of low-density
lipoprotein cholesterol to ubiquinone as a coronary risk factor. New
England Journal of Medicine, Vol. 325, September 12, 1991, pp.
814-15
- Langsjoen, P.H., et al. Long-term efficacy and
safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy.
American Journal of Cardiology, Vol. 65, 1990, pp. 521-23
- Baggio, E., et al. Italian multicenter study on the
safety and efficacy of coenzyme Q10 as adjunctive therapy in heart
failure. Molec. Aspects Med., Vol. 15 (suppl), 1994, pp. S287-94
- Chello, M., et al. Protection of coenzyme Q10 from
myocardial reperfusion injury during coronary artery bypass
grafting. Ann. Thorac. Surg., Vol. 58, 1994, pp. 1427-32
- Judy, W.V., et al. Myocardial preservation by
therapy with coenzyme Q10 during heart surgery. Clin. Invest., Vol.
71 (suppl), 1993, pp. 155-61
- Oda, T. Coenzyme Q10 therapy on the cardiac
dysfunction in patients with mitral valve prolapse. Dose vs effect
and dose vs serum level of coenzyme Q10. In Biomedical and Clinical
Aspects of Coenzyme Q, Vol. 5, eds. Folkers, K. and Yamamura, Y.,
Amsterdam, Elsevier, 1986, pp. 269-80
- Fujioka, T., et al. Clinical study of cardiac
arrhythmias using a 24 hour continuous electrocardiographic recorder
(5th report). Antiarrhythmic action of coenzyme Q10 in diabetes.
Tohoku J. Exp. Med., Vol. 141 (suppl), 1983, p. 453
- Ohnishi, S., et al. The effect of coenzyme Q10 on
premature ventricular contraction. In Biomedical and Clinical
Aspects of Coenzyme Q, Vol. 5, eds. Folkers, K. and Yamamura, Y.,
Amsterdam, Elsevier, 1986, pp. 257-66
- Langsjoen, P.H., et al. Response of patients in
classes III and IV of cardiomyopathy to therapy in a blind and
crossover trial with coenzyme Q10. Proceedings of the National
Academy of Sciences USA, Vol. 82, 1985, p. 4240
- Langsjoen, P., et al. Treatment of essential
hypertension with coenzyme Q10. Molec. Aspects Med., Vol. 15 (suppl),
1994, pp. S265-72
- Digiesi, V., et al. Mechanism of action of coenzyme
Q10 in essential hypertension. Curr. Ther. Res., Vol. 51, 1992, pp.
668-72
- Digiesi, V., et al. Coenzyme Q10 in essential
hypertension. Molec. Aspects Med., Vol. 15 (suppl), 1994, pp.
S257-63
- Ursini, F., et al. Coenzyme Q10 treatment of heart
failure in the elderly: preliminary results. In Biomedical and
Clinical Aspects of Coenzyme Q, Vol. 6, eds. Folkers, K., et al.,
Amsterdam, Elsevier, 1991, pp. 473-80
- Vanfraechem, J.H.P. and Folkers, K. Coenzyme Q10
and physical performance. In Biomedical and Clinical Aspects of
Coenzyme Q, Vol. 3, eds. Folkers, K. and Yamamura, Y., Amsterdam,
Elsevier, 1981, pp. 235- 41
- Folkers, K., et al. The activities of coenzyme Q10
and vitamin B6 for immune responses. Biochemical and Biophysical
Research Communications, Vol. 193, May 28, 1993, pp. 88-92
- Folkers, K., et al. Coenzyme Q10 increases T4/T8
ratios of lymphocytes in ordinary subjects and relevance to patients
having the AIDS related complex. Biochemical and Biophysical
Research Communications, Vol. 176, April 30, 1991, pp. 786-91
- Sovik, O., et al. Coenzyme Q in Duchenne muscular
dystrophy. Acta Paediat. Scand., Vol. 60, 1971, p. 428
- Folkers, K., et al. Effect of coenzyme Q on serum
levels of creatine phosphokinase in preclinical muscular dystrophy.
Proceedings of the National Academy of Sciences USA, Vol. 71, No. 5,
1974, p. 2098
- Folkers, K., et al. Biochemical rationale and the
cardiac response of patients with muscle disease to therapy with
coenzyme Q10. Proceedings of the National Academy of Sciences USA,
Vol. 82, 1985, p. 4513
- Folkers, K., et al. Therapy with coenzyme Q10 for
muscle dystrophy and neurogenic atrophies by double-blind trial. In
Biomedical and Clinical Aspects of Coenzyme Q, Vol. 5, eds. Folkers,
K. and Yamamura, Y., Amsterdam, Elsevier, 1986, pp. 353-58
- Folkers, K. and Simonsen, R. Two successful
double-blind trials with coenzyme Q10 (vitamin Q10) on muscular
dystrophies and neurogenic atrophies. Biochem. Biophys. Acta, Vol.
1271, 1995, pp. 281-86
- van Gaal, L., et al. Exploratory study of coenzyme
Q10 in obesity. In Biomedical and Clinical Aspects of Coenzyme Q,
Vol. 4, eds. Folkers, K. and Yamamura, Y., Amsterdam, Elsevier,
1984, pp. 369-73
- Marincola, Rodolfo. Neurobiology and quantified
pharmaco EEG of coenzyme Q10. Journal of Orthomolecular Medicine,
Vol. 12, No. 2, Second Quarter, 1997, pp. 87-95
- Nakamura, R., et al. Study of CoQ10-enzymes in
gingiva from patients with periodontal disease and evidence for a
deficiency of coenzyme Q10. Proceedings of the National Academy of
Sciences USA, Vol. 71, 1974, p. 1456
- Littarru, G.P., et al. Deficiency of coenzyme Q10
in gingival tissue from patients with periodontal disease.
Proceedings of the National Academy of Sciences USA, Vol. 68, 1971,
p. 2332
- Wilkinson, E.G., et al. Treatment of periodontal
and other soft tissue diseases of the oral cavity with coenzyme Q.
In Biomedical and Clinical Aspects of Coenzyme Q, Vol. 1, eds.
Folkers, K. and Yamamura, Y., Amsterdam, Elsevier, 1977, pp. 251-65
- Hanioka, T., et al. Effect of topical application
of coenzyme Q10 on adult periodontitis. Molec. Aspects Med., Vol. 15
(suppl), 1994, pp. S241-48
- Lockwood, K., et al. Partial and complete
regression of breast cancer in patients in relation to dosage of
coenzyme Q10. Biochemical and Biophysical Research Communications,
Vol. 199, 1994, pp. 1504-08
- Judy, W.V., et al. Coenzyme Q10 reduction of
adriamycin cardiotoxicity. In Biomedical and Clinical Aspects of
Coenzyme Q, Vol. 4, eds. Folkers, K. and Yamamura, Y., Amsterdam,
Elsevier, 1984, pp. 231-41
- Mindell, Earl. Earl Mindell's Vitamin Bible, NY,
Warner Books, 1991, p. 289
- Balch, James F. and Balch, Phyllis A. Prescription
for Nutritional Healing, Garden City Park, NY, Avery Publishing
Group Inc., 1990, p. 11
-------End of References-------
This article was also published in the International
Journal of Alternative and Complementary Medicine, Vol. 16, No 2,
February 1998, pp. 11-12.
BACK
Don't
Forget To Order Your Maca!
|